Vetlife seeks veterinary professionals to join board of trustees
Applications must be received by 5pm on 18 May 2023.
Veterinary professionals with a passion for mental health are invited to apply to join Vetlife’s board of trustees. The role of a trustee requires the attendance at four board meetings per year and an involvement in both operational and strategic work for the charity.
Potential candidates must be a veterinary surgeon or Registered Veterinary Nurse (RVN), and a current Vetlife member. They must be a UK resident and have a good working knowledge of the profession.
Vetlife provides support to members of the UK veterinary community and their families who have emotional, health or financial concerns. It is managed by a board of 12 elected members and has a small number of employed staff.
Vetlife trustee Jo Oakden, said: “Becoming a Vetlife trustee has significantly increased my awareness of the incredible work this charity does. I feel honoured to be able to have a role as part of the board helping to ensure the sustainability and longevity of the charity to continue to support fellow professionals when they need it most.
“It has been a rewarding and humbling experience - highlighting the many challenges faced, but being able to be part of something that can work towards supporting individuals to overcome those challenges.
“The board is an incredibly passionate and compassionate group of individuals, all with aligned values to make a positive difference to those who need support.”
Applications must be received by 5pm on 18 May 2023, and remote interviews are being held on 14 June 2023. Successful candidates will be appointed at Vetlife's Annual General Meeting which is being held in London on 7 September 2023.
Vetlife members can apply to become a trustee in the membership area on the charity's website. Those who would like to discuss the role further should email info@vetlife.org.uk
Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.
